WeVote
Log In

Bill

Bill

S 4150

Relates to the availability of opioid reversal agents

2025 Regular Session Introduced by Joe Addabbo and 9 co-sponsors

Bill S 4150 boosts access to opioid reversal agents like naloxone, aiming to save lives by ensuring availability for at-risk individuals, families, and first responders.

REFERRED TO ALCOHOLISM AND SUBSTANCE USE DISORDERS
0
WeVote Research Nonpartisan
Bill Summary · S 4150

Summary of Bill S 4150: Availability of Opioid Reversal Agents

Bill Overview

  • Bill Number: S 4150
  • Title: Relates to the availability of opioid reversal agents
  • Status: Referred to Alcoholism and Substance Use Disorders
  • Introduced On: February 03, 2025
  • Classification: Bill

Purpose and Intent

The primary purpose of Bill S 4150 is to enhance the availability and accessibility of opioid reversal agents, such as naloxone, which are critical in preventing fatalities from opioid overdoses. The bill aims to address the ongoing opioid crisis by ensuring that these life-saving medications are more readily available to individuals at risk of overdose, as well as to their families, caregivers, and first responders.

Key Provisions

While the specific text of the bill is not provided, the following key provisions are typically included in legislation aimed at improving access to opioid reversal agents:

  • Increased Distribution: The bill may propose measures to increase the distribution of opioid reversal agents through pharmacies, community organizations, and public health initiatives.
  • Training Programs: It could include provisions for training programs for individuals and organizations on how to administer opioid reversal agents effectively.
  • Insurance Coverage: The bill may seek to mandate that health insurance plans cover the cost of opioid reversal agents without requiring prior authorization or imposing high co-pays.
  • Public Awareness Campaigns: The legislation might call for public awareness campaigns to educate the community about the availability and importance of opioid reversal agents.

Affected Parties

The following groups would be significantly impacted by the provisions of Bill S 4150:

  • Individuals at Risk of Opioid Overdose: Those who use opioids, whether prescribed or illicit, would benefit from increased access to reversal agents.
  • Families and Caregivers: Family members and caregivers of individuals at risk would gain easier access to training and resources to help prevent overdose deaths.
  • Healthcare Providers: Medical professionals and first responders would receive support and resources to effectively administer opioid reversal agents in emergency situations.
  • Community Organizations: Nonprofits and community health organizations may receive funding or resources to distribute opioid reversal agents and conduct training.

Procedural Aspects

  • Current Status: As of February 3, 2025, the bill has been referred to the Committee on Alcoholism and Substance Use Disorders for further consideration.
  • Related Legislation: This bill is related to prior-session Bill S 8991 and has a companion bill, A 265, which may address similar issues in the Assembly.

Conclusion

Bill S 4150 represents a proactive approach to combat the opioid crisis by improving access to opioid reversal agents. By facilitating distribution, training, and awareness, the bill aims to save lives and mitigate the impact of opioid overdoses in communities. As the bill progresses through the legislative process, further details and specific provisions will be clarified.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.